A detailed history of Sei Investments CO transactions in Organon & Co. stock. As of the latest transaction made, Sei Investments CO holds 570,912 shares of OGN stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
570,912
Previous 435,539 31.08%
Holding current value
$11.5 Million
Previous $6.28 Million 70.91%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$13.78 - $18.8 $1.87 Million - $2.55 Million
135,373 Added 31.08%
570,912 $10.7 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $174,411 - $275,872
-15,928 Reduced 3.53%
435,539 $6.28 Million
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $40,446 - $57,951
2,438 Added 0.54%
451,467 $7.84 Million
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $640,766 - $818,996
33,252 Added 8.0%
449,029 $9.34 Million
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $2.35 Million - $3.52 Million
109,720 Added 35.85%
415,777 $9.78 Million
Q4 2022

Feb 10, 2023

BUY
$23.31 - $28.61 $134,988 - $165,680
5,791 Added 1.93%
306,057 $8.55 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $1.9 Million - $2.79 Million
-81,357 Reduced 21.32%
300,266 $7.03 Million
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $76,933 - $94,527
2,430 Added 0.64%
381,623 $12.9 Million
Q1 2022

May 13, 2022

BUY
$30.45 - $39.36 $622,154 - $804,203
20,432 Added 5.7%
379,193 $13.1 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $1.72 Million - $2.22 Million
59,830 Added 20.01%
358,761 $10.8 Million
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $5.02 Million - $6.25 Million
175,274 Added 141.74%
298,931 $9.69 Million
Q2 2021

Aug 06, 2021

BUY
$28.45 - $38.0 $3.52 Million - $4.7 Million
123,657 New
123,657 $3.39 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.12B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.